Literature DB >> 31840821

Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies.

Scott Edwards1, Leandro F Vendruscolo2, Nicholas W Gilpin1, Marcin Wojnar3,4, Katie Witkiewitz5.   

Abstract

Alcohol use disorder (AUD) and chronic pain are enduring and devastating conditions that share an intersecting epidemiology and neurobiology. Chronic alcohol use itself can produce a characteristic painful neuropathy, while the regular analgesic use of alcohol in the context of nociceptive sensitization and heightened affective pain sensitivity may promote negative reinforcement mechanisms that underlie AUD maintenance and progression. The goal of this review was to provide a broad translational framework that communicates research findings spanning preclinical and clinical studies, including a review of genetic, molecular, behavioral, and social mechanisms that facilitate interactions between persistent pain and alcohol use. We also consider recent evidence that will shape future investigations into novel treatment mechanisms for pain in individuals suffering from AUD.
© 2019 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol Use Disorder; Comorbidity; Dependence; Hyperalgesia; Nociception

Mesh:

Year:  2020        PMID: 31840821     DOI: 10.1111/acer.14260

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  10 in total

Review 1.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

2.  Elevated customary alcohol consumption attenuates opioid effects.

Authors:  Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman
Journal:  Pharmacol Biochem Behav       Date:  2021-11-04       Impact factor: 3.533

3.  Family History of Alcohol Use Disorder as a Predictor of Endogenous Pain Modulation Among Moderate to Heavy Drinkers.

Authors:  Kyle M White; Lisa R LaRowe; Jessica M Powers; Michael B Paladino; Stephen A Maisto; Michael J Zvolensky; Stephen J Glatt; Joseph W Ditre
Journal:  J Pain       Date:  2021-12-31       Impact factor: 5.383

4.  Neurobiological aspects of pain in the context of alcohol use disorder.

Authors:  Jessica A Cucinello-Ragland; Scott Edwards
Journal:  Int Rev Neurobiol       Date:  2020-10-06       Impact factor: 3.230

5.  A measure of expectancies for alcohol analgesia: Preliminary factor analysis, reliability, and validity.

Authors:  Lisa R LaRowe; Stephen A Maisto; Joseph W Ditre
Journal:  Addict Behav       Date:  2021-01-08       Impact factor: 3.913

6.  Hyperalgesia after a Drinking Episode in Young Adult Binge Drinkers: A Cross-Sectional Study.

Authors:  Dokyoung S You; Hunter A Hahn; Thomas H Welsh; Mary W Meagher
Journal:  Alcohol Alcohol       Date:  2020-10-20       Impact factor: 2.826

Review 7.  The Convergent Neuroscience of Affective Pain and Substance Use Disorder.

Authors:  Amanda R Pahng; Scott Edwards
Journal:  Alcohol Res       Date:  2021-12-16

8.  Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.

Authors:  Courtney M Cameron; Steven Nieto; Lucienne Bosler; Megan Wong; Isabel Bishop; Larissa Mooney; Catherine M Cahill
Journal:  Adv Drug Alcohol Res       Date:  2021-08-03

9.  Alcohol amplifies cingulate cortex signaling and facilitates immobilization-induced hyperalgesia in female rats.

Authors:  Jessica A Cucinello-Ragland; Roshaun Mitchell-Cleveland; W Bradley Trimble; Amy P Urbina; Alice Y Yeh; Kimberly N Edwards; Patricia E Molina; Liz Simon Peter; Scott Edwards
Journal:  Neurosci Lett       Date:  2021-07-17       Impact factor: 3.197

Review 10.  Pathophysiological Consequences of At-Risk Alcohol Use; Implications for Comorbidity Risk in Persons Living With Human Immunodeficiency Virus.

Authors:  Liz Simon; Scott Edwards; Patricia E Molina
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.